Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
ADVL1411 Temozolomide in Children with Refractory or Recurrent Malignancies
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
This study being completed in collaboration with Cincinnati Children's Hospital. For complete information please visit clinicaltrials.gov
IRB Study ID:
141003
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
